e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Genetics in chronic pulmonary diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
v. karunanithi (Stevenage, United Kingdom), T. Win (Stevenage, United Kingdom)
Source:
International Congress 2018 – Genetics in chronic pulmonary diseases
Session:
Genetics in chronic pulmonary diseases
Session type:
Thematic Poster
Number:
4225
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
v. karunanithi (Stevenage, United Kingdom), T. Win (Stevenage, United Kingdom). Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service. 4225
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Source: Eur Respir Rev 2011; 20: 45-52
Year: 2011
Current challenges in the management of nonsmall cell lung cancer brain metastases
Source: Eur Respir J, 55 (1) 1901686; 10.1183/13993003.01686-2019
Year: 2020
Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Targeted therapy in non-small cell lung cancer
Source: Breathe 2012; 8: 206-215
Year: 2012
The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007
Delays in the diagnosis and treatment of non-small cell lung cancer
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
New treatment options for nonsmall cell lung cancer and small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012
Biological therapies in nonsmall cell lung cancer
Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016
Year: 2017
Radiotherapy in the treatment of nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 207–243
Year: 2009
Second line therapy for advanced non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm
Source: Eur Respir J, 55 (2) 1901907; 10.1183/13993003.01907-2019
Year: 2020
Towards personalized treatment in non-small-cell lung carcinoma
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020
Our experience with crizotinib in the treatment of non-small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Should there be a specific management for large cell neuroendocrine carcinoma?
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005
Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001
Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
Source: Eur Respir Rev 2015; 25: 65-70
Year: 2016
Anticancer treatment for advanced non-small cell lung cancer
Source: Breathe 2011; 8: 124-133
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept